INSUBCONTINENT EXCLUSIVE:
Pfizer Inc (PFE.N) said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan
plant, as demand ramps up.Use of the pill, Paxlovid, authorized to treat newly infected, at-risk people to prevent severe illness, has
soared recently as infections rise.Biden administration officials have pushed for the wider use of Paxlovid, which the government
distributes for free.The post Pfizer to spend $120 mln to boost United States COVID pill manufacturing first appeared on Ariana News.
